No BS Just Facts logo
No BS Just Facts
It might be boring, but it's just the facts.

← All stories · business

Bloomberg

Sellas Life Sciences Stock Triples After Cancer Vaccine Data

Tuesday, November 17, 2026


Sellas Life Sciences Group Inc. reported positive results from a late-stage trial of an experimental cancer vaccine designed to treat an aggressive form of blood cancer. The company's stock price tripled following the announcement. Specific efficacy data, patient numbers, and the vaccine's mechanism were not provided in the available information.

Original reporting:

Next story

Google makes it easier to use Gemini without training AI on your data→